Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Revenue

Seoulin Bioscience had revenue of 17.14B KRW in the quarter ending September 30, 2024, a decrease of -12.38%. This brings the company's revenue in the last twelve months to 82.09B, down -2.13% year-over-year. In the year 2023, Seoulin Bioscience had annual revenue of 89.57B, down -14.46%.

• Revenue (ttm): 82.09B
• Revenue Growth: -2.13%
• P/S Ratio: 0.76
• Revenue / Employee: 789.36M
• Employees: 104
• Market Cap: 61.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	89.57B	-15.14B	-14.46%
Dec 31, 2022	104.71B	24.17B	30.01%
Dec 31, 2021	80.54B	15.45B	23.74%
Dec 31, 2020	65.09B	10.68B	19.62%
Dec 31, 2019	54.41B	4.53B	9.09%